Abstract:Objective To explore the action mechanism of Luteolin-induced apoptosis of human colorectal carcinoma HT-29 cells.Methods HT-29 cells were cultured in vitro, and treated with Luteolin at different concentrations.The inhibitory effects of Luteolin on cell proliferation was examined by methyl thiazol tetrazolium (MTT) assay, and the inhibition rate of 80 μmol/L Luteolin for 72 h was 78.72％.The cell apoptosis rate was detected by Annexin V-fluoresceine isothiocyanate (FITC)/propidium iodide (PI) double staining, and the apoptosis rate of HT-29 cells treated with Luteolin for 24 h was (23.78 ± 1.03) ％.The mRNA and protein levels of B cell lymphoma/leukemia-2 associated X protein (bax), B cell lymphoma/leukemia-2 (bcl-2), Caspase-3 and Caspase-9 were detected by real-time quantitative polymerase chain reaction (Real-time PCR) and Western blotting respectively.Results MTT assay showed Luteolin could inhibit the growth and proliferation of HT-29 cells in a time-and concentration-dependent manner.Flow cytometry showed that Luteolin could induce apoptosis of HT-29 cells.Luteolin could activate the expression of bax and Caspase-3,-9, and inhibit the expression of bcl-2.Conclusion Luteolin can significantly inhibit the proliferation and induce the apoptosis of HT-29 cells, which may be associated with mitochondrial pathway.

Luteolin-induced apoptosis of colorectal carcinoma HT-29 cells and mechanism